Blog: Making Tough Conversations Easier When Facing Serious Illness

11/20/19
Historically, health care organizations in the United States have struggled with helping patients navigate their care choices when facing serious illnesses. More

Blog: USP Regulatory Updates Delayed on Appeal

11/20/19
We’ve recently shared communications about updates to existing US Pharmacopeia Convention (USP) Chapters surrounding pharmaceutical compounding regulations as well as a new regulation for handling hazardous drugs in health care facilities. The new and updated rules were scheduled to go into effect Dec. 1. More

9 Characteristics for Care Team Success: Where Does Your Organization Stand?

11/20/19
In today’s increasingly complex health care environment, hospital leaders are challenged to improve patient outcomes, boost productivity, and increase provider and staff retention. Key to achieving these goals is having effective care teams that utilize each member to the fullest extent of their scope of practice and training. More

Biosimilars: Understanding the Impact on the Health System Bottom Line

11/20/19
As blockbuster biologics continue to come off patents, biosimilars are poised to play a crucial role in reshaping the treatment landscape for cancer and other chronic conditions. Besides producing equivalent outcomes to their biologic reference products, biosimilars are also expected to help lower the overall cost of health care. More